Pablo Scodeller

Disrupting Myeloid Persistence and Replenishment Enables Sustained Control of Esophageal Squamous Cell Carcinoma

The paper shows that combining CSF1R inhibition with low-dose decitabine suppresses both myeloid persistence and replenishment, leading to sustained control of ESCC in multiple models.

A neuroprotective tetrapeptide for treatment of acute traumatic brain injury

This study evaluates the neuroprotective effects of the tetrapeptide CAQK in TBI models, showing reduced injury size, inflammation, and functional deficits.

Therapeutic Tumor Macrophage Reprogramming in Breast Cancer Through a Peptide-Drug Conjugate

This paper develops a peptide-drug conjugate, MACTIDE-V, that reprograms tumor-associated macrophages in breast cancer, reducing metastasis and enhancing anti-tumor immunity.

A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25

This paper identifies a cyclic peptide, CES, that targets glioblastoma by binding to aberrantly exposed SNAP25, showing its potential as a drug delivery tool and molecular marker.